Taysha Gene Therapies, Inc. TSHA Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s change in AP?
- Taysha Gene Therapies, Inc. (TSHA) reported change in AP of $1.29M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s change in AP changed year-over-year?
- Taysha Gene Therapies, Inc.'s change in AP increased by 39.7% year-over-year, from $923K to $1.29M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s change in AP?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s change in AP has grown at a -73.0% compound annual growth rate (CAGR), from -$7.8M to -$153K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.